Results 361 to 370 of about 9,546,669 (393)
Some of the next articles are maybe not open access.
The rationale for combination therapy
British Journal of Dermatology, 2001Fungal infections of the nail are common in European populations. There are a number of clinical presentations usually resulting from an infection by one of the dermatophyte species, notably Trichophyton rubrum. A number of modern treatment strategies are available and are generally well tolerated and effective.
openaire +3 more sources
Current Opinion in Oncology, 1991
Encouraging results continue to emerge with the use of chemoradiotherapy. This review of the current literature demonstrates some of the advances that have been achieved in a variety of common malignancies with strategies based on well-defined rationales.
Timothy J. Kinsella, Cornelius J. McGinn
openaire +3 more sources
Encouraging results continue to emerge with the use of chemoradiotherapy. This review of the current literature demonstrates some of the advances that have been achieved in a variety of common malignancies with strategies based on well-defined rationales.
Timothy J. Kinsella, Cornelius J. McGinn
openaire +3 more sources
Combination therapy of dyslipidemia
Current Treatment Options in Cardiovascular Medicine, 2007Clinical trials have demonstrated the benefit of low-density lipoprotein (LDL) cholesterol reduction and, with less robust evidence, reduction of triglyceride levels and increased high-density lipoprotein (HDL) cholesterol in the prevention of atherosclerotic cardiovascular disease.
openaire +3 more sources
Artificial intelligence in drug combination therapy
Briefings Bioinform., 2019Currently, the development of medicines for complex diseases requires the development of combination drug therapies. It is necessary because in many cases, one drug cannot target all necessary points of intervention.
I. Tsigelny
semanticscholar +1 more source
Combination therapy for dyslipidemia
Current Opinion in Cardiology, 2011Residual cardiovascular risk remains in individuals treated with statins and combination therapies may reduce this risk further.Most previous trials of combination therapies have shown a favorable effect on lipid profiles without clinical superiority over statin monotherapy.
openaire +3 more sources
Combination Therapy with Thrombolysis
2017Thrombolysis is the most effective treatment for acute ischemic stroke representing the basic therapeutic standard in the western world. Novel drug treatments are therefore unlikely to be developed as stand-alone approaches and every novel treatment should be considered as combination treatment together with thrombolysis.
Yuluğ, Burak, Schaebitz, Wolf-Ruediger
openaire +3 more sources
Antihypertensive combination therapy
Drugs of Today, 1998The rationale behind employing combination antihypertensive therapy stems from growing evidence that there is a greater need for more aggressive control of systemic arterial pressure to levels below what we have traditionally accepted (140/90 mmHg), and that we have had historically poor control rates with existing approaches to antihypertensive ...
openaire +3 more sources
Combination Therapy in Hypertension
Advances in Therapy, 2013Hypertension is recognized as a major risk factor for cardiovascular and renal diseases and represents the leading cause of mortality worldwide. In spite of proven benefits of hypertension treatment, blood pressure control rates are poor, even in high-income countries with virtually full-access to therapies.
Alejandro de la Sierra, Manuel Gorostidi
openaire +3 more sources
Annals of Internal Medicine, 2004
BACKGROUND Treatment with pegylated interferon (peginterferon) and ribavirin for 48 weeks is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C.
S. Hadziyannis +13 more
semanticscholar +1 more source
BACKGROUND Treatment with pegylated interferon (peginterferon) and ribavirin for 48 weeks is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C.
S. Hadziyannis +13 more
semanticscholar +1 more source
Journal of the American Academy of Dermatology, 1999
Systemic therapies used in psoriasis such as methotrexate, PUVA, cyclosporine, and acitretin often have side effects that limit their usefulness. Combination therapy, an effective strategy for treating psoriasis, allows use of lower doses of medications to achieve superior therapeutic results with fewer side effects.
openaire +3 more sources
Systemic therapies used in psoriasis such as methotrexate, PUVA, cyclosporine, and acitretin often have side effects that limit their usefulness. Combination therapy, an effective strategy for treating psoriasis, allows use of lower doses of medications to achieve superior therapeutic results with fewer side effects.
openaire +3 more sources